Literature DB >> 17049562

Loss of Fas ligand-function improves survival in G93A-transgenic ALS mice.

Susanne Petri1, Mahmoud Kiaei, Elizabeth Wille, Noel Y Calingasan, M Flint Beal.   

Abstract

ALS is a devastating neurodegenerative disorder for which no effective treatment exists. The precise molecular mechanisms underlying the selective degeneration of motor neurons are still unknown. A motor neuron specific apoptotic pathway involving Fas and NO has been discovered. Motor neurons from ALS-mice have an increased sensitivity to Fas-induced cell death via this pathway. In this study we therefore crossed G93A-SOD1 overexpressing ALS mice with Fas ligand (FasL) mutant (gld) mice to investigate whether the reduced Fas signaling could have beneficial effects on motor neuron death. G93A-SOD1 mutant mice with a homozygous FasL mutant showed a modest but statistically significant extension of survival, and reduced loss of motor neurons. These results indicate that motor neuron apoptosis triggered by Fas is relevant in ALS pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17049562     DOI: 10.1016/j.jns.2006.08.013

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  21 in total

Review 1.  Retrograde axonal transport: pathways to cell death?

Authors:  Eran Perlson; Sandra Maday; Meng-Meng Fu; Armen J Moughamian; Erika L F Holzbaur
Journal:  Trends Neurosci       Date:  2010-04-29       Impact factor: 13.837

2.  IFNγ triggers a LIGHT-dependent selective death of motoneurons contributing to the non-cell-autonomous effects of mutant SOD1.

Authors:  J Aebischer; P Cassina; B Otsmane; A Moumen; D Seilhean; V Meininger; L Barbeito; B Pettmann; C Raoul
Journal:  Cell Death Differ       Date:  2010-11-12       Impact factor: 15.828

Review 3.  Motor neuron trophic factors: therapeutic use in ALS?

Authors:  Thomas W Gould; Ronald W Oppenheim
Journal:  Brain Res Rev       Date:  2010-10-21

4.  CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS.

Authors:  David R Beers; Jenny S Henkel; Weihua Zhao; Jinghong Wang; Stanley H Appel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-22       Impact factor: 11.205

5.  Reach task-associated excitatory overdrive of motor cortical neurons following infusion with ALS-CSF.

Authors:  R Sankaranarayani; Mohan Raghavan; A Nalini; T R Laxmi; T R Raju
Journal:  J Neural Transm (Vienna)       Date:  2013-07-31       Impact factor: 3.575

6.  Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis.

Authors:  Arie Neymotin; Noel Y Calingasan; Elizabeth Wille; Nima Naseri; Susanne Petri; Maria Damiano; Karen T Liby; Renee Risingsong; Michael Sporn; M Flint Beal; Mahmoud Kiaei
Journal:  Free Radic Biol Med       Date:  2011-03-30       Impact factor: 7.376

Review 7.  Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes.

Authors:  Marcelo R Vargas; Jeffrey A Johnson
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

8.  Nitration of Hsp90 induces cell death.

Authors:  Maria Clara Franco; Yaozu Ye; Christian A Refakis; Jessica L Feldman; Audrey L Stokes; Manuela Basso; Raquel M Melero Fernández de Mera; Nicklaus A Sparrow; Noel Y Calingasan; Mahmoud Kiaei; Timothy W Rhoads; Thong C Ma; Martin Grumet; Stephen Barnes; M Flint Beal; Joseph S Beckman; Ryan Mehl; Alvaro G Estévez
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

9.  Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: a phase II open label clinical trial.

Authors:  Elijah W Stommel; Jeffrey A Cohen; Camilo E Fadul; Christopher H Cogbill; David J Graber; Linda Kingman; Todd Mackenzie; Jacqueline Y Channon Smith; Brent T Harris
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

10.  A switch in retrograde signaling from survival to stress in rapid-onset neurodegeneration.

Authors:  Eran Perlson; Goo-Bo Jeong; Jenny L Ross; Ram Dixit; Karen E Wallace; Robert G Kalb; Erika L F Holzbaur
Journal:  J Neurosci       Date:  2009-08-05       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.